Biotech Stocks


Biotech Stocks

Biotechnology has been one of the fastest advancing industries in the past decade. With new medicine always being synthesized and new ways to fertilize crops, the sector is diverse and prosperous, especially as corporations look for new findings or better efficiency. Subsequently, the biotech stocks are booming and should continue to rise in the future.
Some of the best biotech stocks to buy in 2014 include Amgen (NYSE:AMGN) and Gilead Sciences (NYSE:GILD) although many smaller biotech corporations are on the rise and worth a consideration. Biotech stocks can cure your ailing portfolio and lead you down the road to recovery.

Biotechnology Sector Quote (CIX: MSECTOR5151)

3 Top Gene Therapy Stocks That Could Soar

By Aaron Levitt, InvestorPlace Contributor
Biotech stocks targeting gene therapy are going to be huge. Here are 3 gene therapy stocks to buy that have a ton of potential.

A New Frontier for CRISPR Stocks: Gene Therapy Cures 10 Babies

By InvestorPlace Research Staff
Scientists took out stem cells from the babies and used a modified HIV virus to deliver the “corrected” copy of the gene back into the patient. It cured the babies with no apparent side effects. This is huge.

5 Biotech Stocks That Could Face M&A Next!

By Aaron Levitt, InvestorPlace Contributor
Big biotech buyouts have already started happening. These five biotech stocks could be the next to go.

3 Big Trends to Play in 2019

By Dana Blankenhorn, InvestorPlace Contributor
Cloud devices are no longer the leading edge of technology, replaced by cloud applications, cloud upgrades and the use of DNA as a computer language.

Should Warren Buffett — And You — Buy More TEVA Stock Right Now?

By Aaron Levitt, InvestorPlace Contributor
Teva's turnaround is working, but a serious worry is now hitting shares. Should you be buying more TEVA stock with this looming danger?

3 Beaten-Down Biotech Stocks to Buy Before the End of 2018

By Tezcan Gecgil, InvestorPlace Contributor
Biotech stocks are likely to continue to be volatile in December, but that may create unique buying opportunities.

5 Biotech Stocks to Scoop Up for Big Dividends

By Aaron Levitt, InvestorPlace Contributor
Biotech stocks can still pay you some big yields. Here are five of the best dividend stocks in the pharma sector.

5 ETFs to Buy to Play the New Economy

By Aaron Levitt, InvestorPlace Contributor
The new economy is here with the break-neck pace of innovation. With that, these are five ETFs to buy for the Fourth Industrial Revolution.

5 Beaten-Down Biotech Stocks to Pick Up from the Wreckage

By Aaron Levitt, InvestorPlace Contributor
After the market's rout, biotech stocks offer a huge value right now. Here are 5 that offer the best opportunities for investors.

7 Lucrative Biotech Stocks With Up to 300% Upside

By Harriet Lefton, Writer, TipRanks
These seven biotech stocks all have support from Wall Street's top-performing analysts and have eye-watering upside potential ahead.

Trade of the Day: Novocure Ltd (NVCR)

By Ken Trester
Biotech firms have been showing strength relative to the rest of the market lately and look like they could be bullish candidates going forward.

5 Biotech Stocks That Could Be the Next Amgen

By Aaron Levitt, InvestorPlace Contributor
Looking for the next big biotech stock? Skip the clinical ones and focus on those with approved drugs. Here are 5 biotech stocks to buy today.

5 AI Biotech Stocks to Bet On Now

By Harriet Lefton, Writer, TipRanks
Marrying the benefits of modern medical science and advanced technology, these biotech stocks leverage AI to help keep people -- and portfolios -- healthier.

Trade of the Day: Exelixis, Inc. (EXEL)

By Ken Trester
My indicators are giving bullish-to-neutral readings this week, a mild downgrade from bullish readings last week. The ratio of advancing issues to declining issues is not as strong as I would like to see.

3 Emerging Technologies Set to Transform the Pharma World

By
Here we discuss three emerging technologies, which the pharma/biotech industry has started adopting, albeit slowly. These are poised to transform the sector by....

5 ‘Strong Buy’ Biotechs That Can Double in 2018

By Harriet Lefton, Writer, TipRanks
Here are five 'Strong Buy' biotech stocks with potential upside of over 100%. These five innovative stocks are worth tracking over the coming months according to the Street.

Is Sanofi’s Bioverative Inc Buyout Just the Start?

By Dana Blankenhorn, InvestorPlace Contributor
Bioverativ and Juno Therapeutics both drew buyout bids as drug companies seek to use CAR-T therapy against cancer profitably.

7 Hot Healthcare Stocks Set to Double in 2018

By Harriet Lefton, Writer, TipRanks
These seven healthcare stocks have full marks from the Street. Here's a closer look at what makes these stocks so special.

7 Life Science Stocks to Buy Today

By Aaron Levitt, InvestorPlace Contributor
You should buy the dip in life science stocks because their long-term futures are assured. Here are seven to pick up today.
Load More